Quanterix Corp

Quanterix Corporation is a life sciences company that provides ultra-sensitive translational research and spatial biology instruments, consumables, and laboratory services. Its proprietary Simoa platforms enable detection of protein biomarkers at concentrations down to the femtomolar range, while its spatial biology platforms allow multi-plexed cellular-level biomarker analysis in intact tissue. In addition to instruments such as the HD-X, SR-X, SP-X, PhenoCycler, and PhenoImager, the company sells consumable assay kits, reagents, and extended service contracts. It also delivers contract research services and clinical diagnostic testing, including laboratory developed tests, through its Accelerator Laboratory. Customers include research laboratories, contract research organizations, academic institutions, and bio-pharmaceutical companies.

The company distributes its products and services worldwide, supporting diagnostic and translational research primarily across neurology, oncology, and immunology. Its commercial footprint includes an installed base of more than 2,500 instruments across global research and clinical settings. Its certified Accelerator Laboratory is located in Bedford, Massachusetts.

Summary of the business section of Quanterix's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“As of December 31, 2025, we had 450 full-time employees, of which 151 worked in sales, sales support, field service, and marketing, 24 worked in engineering and research and development, 198 worked in manufacturing and operations and 77 worked in general and administration.”